| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥23.76B | +200.6% |
| Gross profit | ¥2.17B | — |
| Operating income | ¥1.66B | — |
| Net income | ¥1.34B | +9661.6% |
| Gross margin | 9.1% | Net margin 5.7% |
| Revenue Q/Q | +168.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥21.60B | 90.9% |
| R&D | ¥0.01B | 0.0% |
| SG&A | ¥0.37B | 1.6% |
| Tax & other | ¥0.32B | 1.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ST合纵 ・ 杭州高新 ・ 神思电子 ・ 光力科技 ・ 濮阳惠成 ・ 万孚生物 ・ 首华燃气 ・ 蓝海华腾 ・ 赛升药业 ・ 东杰智能 ・ 蓝晓科技 ・ 恒锋工具
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies